J. Safra Sarasin Holding AG raised its position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 29.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 41,153 shares of the company's stock after purchasing an additional 9,313 shares during the period. J. Safra Sarasin Holding AG's holdings in Nutrien were worth $1,840,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also made changes to their positions in NTR. Norges Bank bought a new position in Nutrien in the fourth quarter worth about $241,958,000. Arrowstreet Capital Limited Partnership lifted its position in Nutrien by 159.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 5,435,627 shares of the company's stock valued at $242,976,000 after acquiring an additional 3,341,169 shares during the last quarter. ARGA Investment Management LP boosted its stake in Nutrien by 25.7% in the fourth quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company's stock valued at $270,396,000 after acquiring an additional 1,236,671 shares in the last quarter. Silchester International Investors LLP grew its holdings in Nutrien by 9.5% in the fourth quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company's stock worth $523,268,000 after purchasing an additional 1,009,895 shares during the last quarter. Finally, Barclays PLC increased its position in shares of Nutrien by 192.7% during the fourth quarter. Barclays PLC now owns 411,056 shares of the company's stock worth $18,395,000 after purchasing an additional 854,543 shares in the last quarter. Institutional investors own 63.10% of the company's stock.
Nutrien Price Performance
NTR traded up $1.35 during midday trading on Monday, hitting $55.40. 1,596,806 shares of the company traded hands, compared to its average volume of 2,096,380. The business has a 50 day simple moving average of $51.12 and a two-hundred day simple moving average of $49.40. Nutrien Ltd. has a 52-week low of $43.70 and a 52-week high of $60.87. The company has a market capitalization of $27.08 billion, a price-to-earnings ratio of 40.44, a PEG ratio of 1.19 and a beta of 0.77. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38.
Nutrien (NYSE:NTR - Get Free Report) last announced its earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.09). The business had revenue of $5.08 billion for the quarter, compared to analyst estimates of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. On average, equities analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.
Nutrien Cuts Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, April 10th. Investors of record on Monday, March 31st were paid a dividend of $0.545 per share. The ex-dividend date was Monday, March 31st. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.94%. Nutrien's payout ratio is currently 159.12%.
Wall Street Analyst Weigh In
NTR has been the topic of several recent analyst reports. Mizuho upped their target price on Nutrien from $52.00 to $55.00 and gave the company a "neutral" rating in a research report on Thursday, February 20th. Piper Sandler increased their price objective on shares of Nutrien from $58.00 to $63.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. JPMorgan Chase & Co. raised shares of Nutrien from an "underweight" rating to a "neutral" rating and boosted their target price for the stock from $40.00 to $50.00 in a research report on Monday, January 13th. Wells Fargo & Company raised their price target on shares of Nutrien from $53.00 to $56.00 and gave the stock an "equal weight" rating in a report on Friday, February 21st. Finally, Berenberg Bank upped their target price on Nutrien from $54.00 to $59.00 and gave the company a "buy" rating in a research report on Tuesday, April 15th. Two analysts have rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $59.27.
Check Out Our Latest Research Report on Nutrien
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Further Reading
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
